Logo image of UCL

UCLOUDLINK GROUP INC (UCL) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:UCL - US90354D1046 - ADR

2.0717 USD
+0.17 (+8.75%)
Last: 12/17/2025, 4:30:01 PM
Fundamental Rating

3

Overall UCL gets a fundamental rating of 3 out of 10. We evaluated UCL against 22 industry peers in the Wireless Telecommunication Services industry. UCL has an average financial health and profitability rating. UCL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year UCL has reported negative net income.
In the past year UCL has reported a negative cash flow from operations.
In multiple years UCL reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: UCL reported negative operating cash flow in multiple years.
UCL Yearly Net Income VS EBIT VS OCF VS FCFUCL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

The Return On Assets of UCL (11.06%) is better than 95.45% of its industry peers.
UCL has a better Return On Equity (24.79%) than 86.36% of its industry peers.
With an excellent Return On Invested Capital value of 15.62%, UCL belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
ROA 11.06%
ROE 24.79%
ROIC 15.62%
ROA(3y)-10.45%
ROA(5y)-33.28%
ROE(3y)-58.54%
ROE(5y)-103.86%
ROIC(3y)N/A
ROIC(5y)N/A
UCL Yearly ROA, ROE, ROICUCL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 -200

1.3 Margins

Looking at the Profit Margin, with a value of 9.23%, UCL is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
UCL's Profit Margin has improved in the last couple of years.
UCL has a Operating Margin (9.22%) which is in line with its industry peers.
In the last couple of years the Operating Margin of UCL has declined.
UCL has a Gross Margin (49.77%) which is in line with its industry peers.
In the last couple of years the Gross Margin of UCL has grown nicely.
Industry RankSector Rank
OM 9.22%
PM (TTM) 9.23%
GM 49.77%
OM growth 3YN/A
OM growth 5Y-2.15%
PM growth 3YN/A
PM growth 5Y26.84%
GM growth 3Y17.9%
GM growth 5Y3.39%
UCL Yearly Profit, Operating, Gross MarginsUCL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

4

2. Health

2.1 Basic Checks

UCL has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, UCL has more shares outstanding
Compared to 5 years ago, UCL has more shares outstanding
Compared to 1 year ago, UCL has a worse debt to assets ratio.
UCL Yearly Shares OutstandingUCL Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
UCL Yearly Total Debt VS Total AssetsUCL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

UCL has an Altman-Z score of -1.09. This is a bad value and indicates that UCL is not financially healthy and even has some risk of bankruptcy.
UCL has a worse Altman-Z score (-1.09) than 86.36% of its industry peers.
UCL has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.24, UCL belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z -1.09
ROIC/WACC1.88
WACC8.32%
UCL Yearly LT Debt VS Equity VS FCFUCL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

UCL has a Current Ratio of 1.68. This is a normal value and indicates that UCL is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of UCL (1.68) is better than 86.36% of its industry peers.
UCL has a Quick Ratio of 1.55. This is a normal value and indicates that UCL is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.55, UCL belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.68
Quick Ratio 1.55
UCL Yearly Current Assets VS Current LiabilitesUCL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

1

3. Growth

3.1 Past

UCL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -118.18%.
UCL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.89% yearly.
UCL shows a decrease in Revenue. In the last year, the revenue decreased by -2.48%.
The Revenue for UCL have been decreasing by -10.37% on average. This is quite bad
EPS 1Y (TTM)-118.18%
EPS 3YN/A
EPS 5Y3.89%
EPS Q2Q%-77.78%
Revenue 1Y (TTM)-2.48%
Revenue growth 3Y7.48%
Revenue growth 5Y-10.37%
Sales Q2Q%-16.03%

3.2 Future

Based on estimates for the next years, UCL will show a very negative growth in Earnings Per Share. The EPS will decrease by -41.98% on average per year.
Based on estimates for the next years, UCL will show a small growth in Revenue. The Revenue will grow by 6.48% on average per year.
EPS Next Y-116.83%
EPS Next 2Y-41.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-6.18%
Revenue Next 2Y6.48%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
UCL Yearly Revenue VS EstimatesUCL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
UCL Yearly EPS VS EstimatesUCL Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 -0.5 -1

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for UCL. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 51.28, the valuation of UCL can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of UCL indicates a slightly more expensive valuation: UCL is more expensive than 77.27% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.66, UCL is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 51.28
UCL Price Earnings VS Forward Price EarningsUCL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

UCL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. UCL is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 0.93
UCL Per share dataUCL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

UCL's earnings are expected to decrease with -41.98% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-41.98%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

UCL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

UCLOUDLINK GROUP INC

NASDAQ:UCL (12/17/2025, 4:30:01 PM)

2.0717

+0.17 (+8.75%)

Chartmill FA Rating
GICS IndustryGroupTelecommunication Services
GICS IndustryWireless Telecommunication Services
Earnings (Last)11-12 2025-11-12/bmo
Earnings (Next)03-11 2026-03-11/amc
Inst Owners17.94%
Inst Owner Change93.94%
Ins Owners8.94%
Ins Owner ChangeN/A
Market Cap77.96M
Revenue(TTM)85.24M
Net Income(TTM)7.87M
Analysts80
Price Target8.16 (293.88%)
Short Float %0.29%
Short Ratio0.42
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.99%
Min EPS beat(2)-0.99%
Max EPS beat(2)-0.99%
EPS beat(4)1
Avg EPS beat(4)-160.89%
Min EPS beat(4)-692.08%
Max EPS beat(4)50.5%
EPS beat(8)4
Avg EPS beat(8)-31.19%
EPS beat(12)7
Avg EPS beat(12)3.62%
EPS beat(16)7
Avg EPS beat(16)-89.25%
Revenue beat(2)0
Avg Revenue beat(2)-10.91%
Min Revenue beat(2)-16.59%
Max Revenue beat(2)-5.23%
Revenue beat(4)2
Avg Revenue beat(4)-4.41%
Min Revenue beat(4)-16.59%
Max Revenue beat(4)2.2%
Revenue beat(8)4
Avg Revenue beat(8)-3.73%
Revenue beat(12)5
Avg Revenue beat(12)-2.95%
Revenue beat(16)7
Avg Revenue beat(16)-2.16%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-300%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 51.28
P/S 0.91
P/FCF N/A
P/OCF N/A
P/B 2.46
P/tB 2.5
EV/EBITDA 0.93
EPS(TTM)-0.02
EYN/A
EPS(NY)0.04
Fwd EY1.95%
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS2.27
BVpS0.84
TBVpS0.83
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 11.06%
ROE 24.79%
ROCE 23.93%
ROIC 15.62%
ROICexc N/A
ROICexgc N/A
OM 9.22%
PM (TTM) 9.23%
GM 49.77%
FCFM N/A
ROA(3y)-10.45%
ROA(5y)-33.28%
ROE(3y)-58.54%
ROE(5y)-103.86%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-2.15%
PM growth 3YN/A
PM growth 5Y26.84%
GM growth 3Y17.9%
GM growth 5Y3.39%
F-Score3
Asset Turnover1.2
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Debt/EBITDA 0.75
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.68
Quick Ratio 1.55
Altman-Z -1.09
F-Score3
WACC8.32%
ROIC/WACC1.88
Cap/Depr(3y)133.27%
Cap/Depr(5y)103.42%
Cap/Sales(3y)2.46%
Cap/Sales(5y)2.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-118.18%
EPS 3YN/A
EPS 5Y3.89%
EPS Q2Q%-77.78%
EPS Next Y-116.83%
EPS Next 2Y-41.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.48%
Revenue growth 3Y7.48%
Revenue growth 5Y-10.37%
Sales Q2Q%-16.03%
Revenue Next Year-6.18%
Revenue Next 2Y6.48%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y85.18%
EBIT growth 3YN/A
EBIT growth 5Y-12.3%
EBIT Next Year25.81%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-107.68%
FCF growth 3YN/A
FCF growth 5Y12.11%
OCF growth 1Y-107.68%
OCF growth 3YN/A
OCF growth 5Y9.78%

UCLOUDLINK GROUP INC / UCL FAQ

What is the ChartMill fundamental rating of UCLOUDLINK GROUP INC (UCL) stock?

ChartMill assigns a fundamental rating of 3 / 10 to UCL.


What is the valuation status of UCLOUDLINK GROUP INC (UCL) stock?

ChartMill assigns a valuation rating of 1 / 10 to UCLOUDLINK GROUP INC (UCL). This can be considered as Overvalued.


How profitable is UCLOUDLINK GROUP INC (UCL) stock?

UCLOUDLINK GROUP INC (UCL) has a profitability rating of 5 / 10.


How financially healthy is UCLOUDLINK GROUP INC?

The financial health rating of UCLOUDLINK GROUP INC (UCL) is 4 / 10.